Research Registry for Adults with Aggressive Pituitary Tumors Discussed at the HYPOcare National Meeting

What this Trial Is About

Researchers are studying aggressive pituitary tumors through a national research registry called HYPOcare, which gathers patient information from a multidisciplinary consultation meeting. This meeting brings together experts from across the country to help guide patient care and collect one of the largest cohorts of patients with aggressive pituitary tumors both nationally and internationally. Currently, the data is used only for clinical management and not for research purposes. The study involves adult patients with pituitary tumors whose medical files have been reviewed by the HYPOcare consultation meeting. There is a single group of participants, and the study is observational, meaning no new treatments or interventions are given as part of the trial. The registry collects clinical data to support research on the characteristics of aggressive pituitary tumors. Participants provide their medical information for analysis, and researchers will study the aggressiveness of the tumors using transcriptome analysis over a three-year period. No experimental treatments are administered, and no direct patient visits or interventions are required as part of this observational research. The study aims to improve understanding and future management of aggressive pituitary tumors through data collection and analysis.

A Research Registry on Aggressive PitNETs